Pine Bridge Investments, L.P. Amphastar Pharmaceuticals, Inc. Transaction History

Pine Bridge Investments, L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$12.66 - $20.08 $404,854 - $642,138	-31,979 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$17.07 - $20.64 $204,020 - $246,689	-11,952 Reduced 27.21%	31,979 $616,000
Q3 2019 Nov 13, 2019	BUY	$19.12 - $22.62 $101,680 - $120,293	5,318 Added 13.77%	43,931 $871,000
Q2 2019 Aug 13, 2019	BUY	$18.92 - $22.96 $730,557 - $886,554	38,613 New	38,613 $815,000
Q1 2019 May 14, 2019	SELL	$19.46 - $25.28 $69,997 - $90,932	-3,597 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$17.72 - $22.51 $47,418 - $60,236	2,676 Added 290.55%	3,597 $72,000
Q3 2018 Nov 13, 2018	BUY	$15.39 - $19.38 $14,174 - $17,848	921 New	921 $18,000
Q4 2017 Feb 09, 2018	SELL	$17.76 - $19.75 $78,392 - $87,176	-4,414 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$14.73 - $17.99 $4,212 - $5,145	-286 Reduced 6.09%	4,414 $79,000
Q2 2017 Aug 11, 2017	BUY	N/A	4,700	4,700 $84,000

283

34.8M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.75B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.